<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Braga A</submitter><funding>Donald P. Goldstein MD Trophoblastic Tumor Registry Endowment, the Dyett Family Trophoblastic Disease Research and Registry Endowment and Keith Higgins and the Andrea S. Higgins Research Fund</funding><funding>Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro – FAPERJ</funding><funding>National Council for Scientific and Technological Development – CNPq</funding><pagination>e0277892</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9714693</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among Brazilian women.&lt;h4>Methods&lt;/h4>Retrospective cohort study of patients with CHM followed at Rio de Janeiro Federal University, from January/2015-December/2020. Before molar evacuation, all patients underwent a medical evaluation, complete blood count and hCG measurement, in addition to other routine preoperative tests. The primary outcome was the occurrence of postmolar GTN.&lt;h4>Results&lt;/h4>From 827 cases of CHM treated initially at the Reference Center, 696 (84.15%) had spontaneous remission and 131 (15.85%) developed postmola</pubmed_abstract><journal>PloS one</journal><pubmed_title>Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.</pubmed_title><pmcid>PMC9714693</pmcid><funding_grant_id>E-26/201.166/2022</funding_grant_id><funding_grant_id>1</funding_grant_id><funding_grant_id>311862/2020-9</funding_grant_id><pubmed_authors>Maesta I</pubmed_authors><pubmed_authors>Bessel M</pubmed_authors><pubmed_authors>Berkowitz RS</pubmed_authors><pubmed_authors>Elias KM</pubmed_authors><pubmed_authors>Rezende Filho J</pubmed_authors><pubmed_authors>Braga A</pubmed_authors><pubmed_authors>Giongo Pedrotti L</pubmed_authors><pubmed_authors>Vieira Dos Santos Esteves AP</pubmed_authors><pubmed_authors>Amim Junior J</pubmed_authors><pubmed_authors>Horowitz NS</pubmed_authors><pubmed_authors>Canelas AC</pubmed_authors><pubmed_authors>Torres B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.</name><description>&lt;h4>Objective&lt;/h4>To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among Brazilian women.&lt;h4>Methods&lt;/h4>Retrospective cohort study of patients with CHM followed at Rio de Janeiro Federal University, from January/2015-December/2020. Before molar evacuation, all patients underwent a medical evaluation, complete blood count and hCG measurement, in addition to other routine preoperative tests. The primary outcome was the occurrence of postmolar GTN.&lt;h4>Results&lt;/h4>From 827 cases of CHM treated initially at the Reference Center, 696 (84.15%) had spontaneous remission and 131 (15.85%) developed postmola</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-21T23:17:47.775Z</modification><creation>2025-04-05T19:06:51.66Z</creation></dates><accession>S-EPMC9714693</accession><cross_references><pubmed>36454778</pubmed><doi>10.1371/journal.pone.0277892</doi></cross_references></HashMap>